EyePoint Pharmaceuticals, Inc. Uncategorized Contracts & Agreements
17 Contracts & Agreements
- Product Rights Agreement, dated May 17, 2023, by and between EyePoint Pharmaceuticals, Inc. and Alimera Sciences, Inc (Filed With SEC on May 18, 2023)
- Commercial Alliance Expansion Term Letter Agreement dated December 6, 2021 between EyePoint Pharmaceuticals, Inc. and ImprimisRx, LLC (Filed With SEC on March 14, 2022)
- Description of Securities of EyePoint Pharmaceuticals, Inc (Filed With SEC on March 12, 2021)
- Amendment One to the Commercial Alliance Agreement dated November 12, 2020 between EyePoint Pharmaceuticals, Inc. and ImprimisRx, LLC (Filed With SEC on March 12, 2021)
- Commercial Alliance Agreement, dated as of August 1, 2020 between EyePoint Pharmaceuticals, Inc. and ImprimisRx, LLC (Filed With SEC on November 6, 2020)
- Description of Securities of EyePoint Pharmaceuticals, Inc (Filed With SEC on March 16, 2020)
- Agreement, dated April 11, 2017, by and between pSivida Corp., pSiMedica Limited and Pfizer, Inc (Filed With SEC on September 13, 2017)
- pSivida 480 Pleasant Street Suite B300 Watertown, MA 02472 (Filed With SEC on January 10, 2017)
- - 2 - (Filed With SEC on November 8, 2016)
- - 2 - (Filed With SEC on November 8, 2016)
- AGREEMENT (Filed With SEC on November 8, 2016)
- PSIVIDA CORP. (Filed With SEC on September 10, 2015)
- Rodman & Renshaw, LLC 1251 Avenue of the Americas, 20th Floor, New York, NY 10020 Tel: 212 356 0500 Fax: 212 5815690 www.rodm.com Member: FINRA, SIPC (Filed With SEC on August 2, 2012)
- CONFIDENTIAL TREATMENT REQUESTED (Filed With SEC on September 13, 2011)
- pSivida Corp. 400 Pleasant Street Watertown, MA 02472 (Filed With SEC on December 21, 2010)
- pSivida Corp. 400 Pleasant Street Watertown, MA 02472 (Filed With SEC on December 21, 2010)
- CONFIDENTIAL TREATMENT REQUESTED (Filed With SEC on April 26, 2010)
